Drugs that contain Emtricitabine; Tenofovir Alafenamide Fumarate
1. List of Descovy drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7390791 | GILEAD SCIENCES INC | Prodrugs of phosphonate nucleotide analogues |
Apr, 2025
(2 years from now) | |
| US8754065 | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Aug, 2032
(9 years from now) | |
| US9296769 | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Aug, 2032
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7803788 | GILEAD SCIENCES INC | Prodrugs of phosphonate nucoleotide analogues |
Feb, 2022
(1 year, 1 month ago) | |
|
US7390791
(Pediatric) | GILEAD SCIENCES INC | Prodrugs of phosphonate nucleotide analogues |
Oct, 2025
(2 years from now) | |
|
US9296769
(Pediatric) | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Feb, 2033
(9 years from now) | |
|
US8754065
(Pediatric) | GILEAD SCIENCES INC | Tenofovir alafenamide hemifumarate |
Feb, 2033
(9 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity (ODE) | Sep 28, 2024 |
Market Authorisation Date: 04 April, 2016
Treatment: Treatment of hiv-1 infection; Prophylaxis of hiv-1 infection; Treatment of hiv infection
Dosage: TABLET;ORAL
DESCOVY family patents
17
United States
9
Japan
6
European Union
5
Australia
5
Norway
4
China
4
Canada
4
New Zealand
3
Denmark
3
Hong Kong
3
Slovenia
3
Lithuania
3
Hungary
3
Croatia
3
Portugal
3
Cyprus
3
Spain
3
Korea, Republic of
2
South Africa
2
Mexico
2
AP
2
Brazil
2
Poland
2
Czech Republic
2
Ukraine
2
EA
1
Israel
1
OA
1
Turkey
1
Belgium
1
Morocco
1
Uruguay
1
Costa Rica
1
Moldova, Republic of
1
Singapore
1
Colombia
1
Argentina
1
Netherlands
1
Peru
1
San Marino
1
Iceland
1
Chile
1
RS
1
Taiwan, Province of China
1
Luxembourg
1
India
1
Ecuador
1
Bulgaria
1
Estonia
1
ME
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic